| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.04 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |